INO Inovio Pharmaceuticals
- 12.1000
- +0.0900+0.75%
Inovio Pharmaceuticals News
Press Release: INOVIO Reports Inducement Grants Under Inducement Plan
INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., May 1, 2024 PLYMOUTH MEETING, Pa., May 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology compa
INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
INOVIO to Participate in Upcoming Investor Conferences in May
INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from...
Express News | Inovio Pharmaceuticals Form 13G Shows Deep Track Capital, LP Reported A 9.99% Stake In The Co As Of April, 16, 2024
Express News | Deep Track Capital, LP Reports 9.99% Passive Stake in Inovio Pharmaceuticals Inc as of April 16 - SEC Filing
Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?
Inovio Pharmaceuticals Inc (NASDAQ:INO) shares are trading lower Tuesday after the company announced the pricing of a public offering.What Happened: Inovio announced the pricing of an underwritten off
Express News | INOVIO Shares Are Trading Lower After the Company Announced the Pricing of Its $36 Million Underwritten Offering
Inovio Pharmaceuticals Shares Slump Pre-Bell After Pricing of $36 Million Offering of Common Stock, Warrants
Inovio Pharmaceuticals (INO) shares slid 24% in premarket activity Tuesday after the company said late Monday that it priced its underwritten offering of common stock and pre-funded warrants, for gros
Top Premarket Decliners
Ryvyl (RVYL) shares fell 39% after the company said it has launched a public offering of shares. Skillsoft Corp. (SKIL) shares dropped 20% after the company posted lower fiscal Q4 revenue. Inovio Phar
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersDynatronics (NASDAQ:DYNT) stock rose 84.9% to $0.69 during Tuesday's pre-market session. The company's market cap stands at $3.3 million. BioRestorative Therapies (NASDAQ:BRTX) shares rose 23.4
Inovio Falls After Pricing Stock Offering
Express News | Reported Earlier, INOVIO Prices $36M Underwritten Offering Of 2,536,258 Common Stock At $7.693/Share
Inovio Shares Fall 23% After Underwritten Offering Prices
Shares of biotechnology company Inovio were trading lower in the after-hours market following news it priced an underwritten offering of stock and warrants.
Express News | Inovio Pharmaceuticals Inc - Pricing of an Underwritten Offering of 2.5 Mln Shares of Its Common Stock at an Offering Price of $7.693 per Share
Express News | Inovio Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Express News | WHO's Tedros Adhanom Ghebreyesus Posts On X "In #DRC Alone, More Than 4500 Cases of #mpox and Almost 300 Deaths Have Been Reported This Year. That Is Triple the Number Reported at This Time Last Year. The Recent Surge in Cases and Deaths Among Children Is
12 Health Care Stocks Moving In Friday's After-Market Session
GainersLongeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday's after-market session. The company's market cap stands at $8.2 million. Adial Pharmaceuticals (NASDAQ:ADIL) shares increased by
Inovio Pharmaceuticals: A Strong Buy on Promising IL-12 Therapy Developments and Market Interest
INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
PLYMOUTH MEETING, Pa., March 26, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Peering Into Inovio Pharmaceuticals's Recent Short Interest
Inovio Pharmaceuticals's (NYSE:INO) short percent of float has risen 22.31% since its last report. The company recently reported that it has 1.74 million shares sold short, which is 7.73% of all regul
Analysis
Price Target
No Data
